Science Explorer Interactive view Map
Company · Cambridge · United Kingdom

Napp Pharmaceuticals (United Kingdom)

napp.co.ukROR OpenAlex
Research works
80
▼ 31% vs 2013–17
Citations
3k
38.2 per fractional work
Top-10% rate
5.0%
record average 16.5%
Open access
18%
world 28%

Not ranked overall: Napp Pharmaceuticals (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 5.06× its world share, 0 worksBiochemistry, Geneti…Neuroscience: 0.64× its world share, 0 worksNeuroscienceChemistry: 7.05× its world share, 0 worksChemistryEngineering: 0.37× its world share, 0 worksEngineeringHealth Professions: 2.52× its world share, 0 worksHealth ProfessionsMedicine: 2.30× its world share, 1 worksMedicineVeterinary: 4.88× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 1.03× its world share, 0 worksBusiness, Management…Social Sciences: 0.05× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Chemistry, 7.0×. Every wedge is a field page.

Which keywords describe research at Napp Pharmaceuticals (United Kingdom)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Pain Management, Inflammation, Vaccine, Immune Response, Gene Therapy, Postoperative Pain and Chronic Pain.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology13▲ 3.9×33 topics
  2. Inflammation6▲ 3.0×17 topics
  3. Pain Management4▲ 21×5 topics
  4. Vaccine4▲ 11×4 topics
  5. Immune Response3▲ 6.6×5 topics
  6. Treatment3▲ 3.2×7 topics
  7. Gene Therapy3▲ 14×3 topics
  8. Postoperative Pain3▲ 38×3 topics
  9. Chronic Pain3▲ 16×4 topics
  10. AAV3▲ 54×1 topic
  11. Viral Vectors3▲ 54×1 topic
  12. Cancer Therapy3▲ 5.1×10 topics
  13. Pharmacokinetics3▲ 12×4 topics
  14. Clinical Trials2▲ 5.1×6 topics
  15. Diagnosis2▲ 3.1×8 topics
  16. Medicinal Chemistry2▲ 8.1×4 topics
  17. Herpes Zoster2▲ 65×1 topic
  18. Herpesviruses2▲ 65×1 topic
  19. Glycosylation2▲ 13×3 topics
  20. Pathogenesis2▲ 4.9×8 topics
  21. Infection2▲ 9.3×3 topics
  22. Method Validation2▲ 35×2 topics
  23. Pain Assessment Tools2▲ 50×2 topics
  24. Drug Development2▲ 18×3 topics
  25. Green Analytical Chemistry2▲ 27×1 topic
  26. Pharmaceutical Analysis2▲ 80×1 topic
  27. Analgesia2▲ 31×2 topics
  28. Monoclonal Antibodies2▲ 16×3 topics
  29. Adverse Drug Reactions2▲ 32×2 topics
  30. Medication Adherence2▲ 36×2 topics
  31. Therapeutic Antibodies2▲ 17×2 topics
  32. Off-Label Drug Use2▲ 54×1 topic
  33. Pediatric Pharmacokinetics2▲ 54×1 topic
  34. Organometallic Chemistry2▲ 13×3 topics
  35. Perioperative Care2▲ 16×2 topics
  36. Antiepileptic Drugs1▲ 18×2 topics
  37. Genomic Studies1▲ 20×2 topics
  38. Regional Anesthesia1▲ 32×1 topic
  39. Surgical Outcome1▲ 32×1 topic
  40. Cyclodextrins1▲ 73×1 topic

Which research topics does Napp Pharmaceuticals (United Kingdom) publish most on?

By volume in 2022–2025: Cancer-related Molecular Pathways, Ubiquitin and proteasome pathways, RNA modifications and cancer and Innovative Approaches in Technology and Social Development.

Cancer-related Molecular…1Cancer-related Molecular Pathways: 1 fractional worksUbiquitin and proteasome pathways: 0 fractional worksRNA modifications and ca…0RNA modifications and cancer: 0 fractional worksInnovative Approaches in Technology and Social Development: 0 fractional worksCommunity Health and Development: 0 fractional worksHealth Policy Implementation Science: 0 fractional worksOxidative Organic Chemistry Reactions: 0 fractional worksInnovative Microfluidic and Catalytic Techniques Innovation: 0 fractional worksCatalytic C–H Functionalization Methods: 0 fractional works
OncologyMolecular BiologyManagement of Technology and InnovationGeneral Health Professions2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer-related Molecular Pathways Oncology 1 works
  2. 2 Ubiquitin and proteasome pathways Molecular Biology 0 works
  3. 3 RNA modifications and cancer Molecular Biology 0 works
  4. 4 Innovative Approaches in Technology and Social Development Management of Technology and Innovation 0 works
  5. 5 Community Health and Development General Health Professions 0 works
  6. 6 Health Policy Implementation Science General Health Professions 0 works
  7. 7 Oxidative Organic Chemistry Reactions Organic Chemistry 0 works
  8. 8 Innovative Microfluidic and Catalytic Techniques Innovation Biomedical Engineering 0 works
  9. 9 Catalytic C–H Functionalization Methods Organic Chemistry 0 works
  10. 10 Mitochondrial Function and Pathology Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available17.6%not open82.4%

World: 28% of research is openly available.

with international co-authors20.8%domestic only79.2%

World: 19% is written across borders.

How has Napp Pharmaceuticals (United Kingdom)'s research output changed?

Output in 2018–2022 was 31% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.